175136-34-2 Usage
Description
3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-AMINE is an organic compound that serves as a crucial intermediate in various chemical and pharmaceutical processes. Its unique chemical structure allows it to be a versatile building block for the synthesis of different compounds.
Uses
Used in Organic Synthesis:
3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-AMINE is used as a key intermediate for the synthesis of various organic compounds. Its chemical reactivity and structural properties make it a valuable component in the creation of a wide range of molecules.
Used in Pharmaceutical Industry:
3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-AMINE is used as a vital building block in the development of new pharmaceuticals. Its incorporation into drug molecules can potentially enhance their efficacy, selectivity, and pharmacokinetic properties.
Used in Agrochemicals:
In the agrochemical industry, 3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-AMINE is used as a starting material for the synthesis of various agrochemical products. Its presence in these compounds can contribute to their effectiveness in protecting crops and improving agricultural yields.
Used in Dye Industry:
3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-AMINE is also utilized in the dye industry as a raw material for the production of different types of dyes. Its chemical structure can be manipulated to create dyes with specific color properties and stability, catering to various applications in textiles, plastics, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 175136-34-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,1,3 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 175136-34:
(8*1)+(7*7)+(6*5)+(5*1)+(4*3)+(3*6)+(2*3)+(1*4)=132
132 % 10 = 2
So 175136-34-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2/c10-7-2-3-8-9(6-7)12-5-1-4-11-8/h2-3,6H,1,4-5,10H2
175136-34-2Relevant articles and documents
Guanidine compound for preventing and treating chronic pain medication (by machine translation)
-
, (2020/08/27)
The invention relates to a guanidine compound as shown in general formula (I) as a guanidine compound for preventing and treating chronic pain disease. A pharmaceutically acceptable salt thereof, a prodrug thereof, a solvate thereof, a deuterated substanc
Exploring Epidermal Growth Factor Receptor (EGFR) inhibitor features: The role of fused dioxygenated rings on the quinazoline scaffold
Chilin, Adriana,Conconi, Maria Teresa,Marzaro, Giovanni,Guiotto, Adriano,Urbani, Luca,Tonus, Francesca,Parnigotto, Pierpaolo
supporting information; experimental part, p. 1862 - 1866 (2010/08/06)
A number of dioxolane, dioxane, and dioxepine quinazoline derivatives have been synthetized, and evaluated as EGFR inhibitors. Their cytotoxic activity has been tested against two cell, lines overexpressing and not expressing EGFR. Most derivatives were a